Among them, AABs against ADRB2 are considered to play a crucial role in endothelial dysfunction in ME/CFS, as reviewed in Wirth 2020 (72). The gene discussed is ADRB2; the disease is myalgic encephalomeyelitis/chronic fatigue syndrome.